LANCHBURY JERRY S 4

4 · MYRIAD GENETICS INC · Filed Aug 5, 2021

Insider Transaction Report

Form 4

Period: 2021-08-03

MYRIAD GENETICS INCMYGN

LANCHBURY JERRY S

See Remarks

Transactions

Sale
Common Stock
[F1]
2021-08-03$34.00/sh−4,170$141,780→ 232,550 total
Exercise/Conversion
Common Stock
[F1]
2021-08-03$26.49/sh+16,225$429,800→ 248,775 total
Sale
Common Stock
[F1]
2021-08-03$33.99/sh−16,225$551,488→ 232,550 total
Exercise/Conversion
Common Stock
[F1]
2021-08-03$27.07/sh+1,775$48,049→ 234,325 total
Sale
Common Stock
[F1]
2021-08-03$35.07/sh−1,775$62,249→ 232,550 total
Exercise/Conversion
Common Stock
[F1]
2021-08-03$23.98/sh+27,830$667,363→ 260,380 total
Sale
Common Stock
[F1]
2021-08-03$34.00/sh−27,830$946,220→ 232,550 total
Exercise/Conversion
Common Stock
[F1]
2021-08-03$23.98/sh+4,170$99,997→ 236,720 total
Exercise/Conversion
Common Stock
[F1]
2021-08-04$27.07/sh+38,225$1,034,751→ 270,775 total
Sale
Common Stock
[F1][F2]
2021-08-04$35.24/sh−38,225$1,347,171→ 232,550 total
Exercise/Conversion
Common Stock
[F1]
2021-08-04$27.07/sh+11,775$318,749→ 244,325 total
Sale
Common Stock
[F1][F3]
2021-08-04$35.57/sh−11,775$418,856→ 232,550 total
Exercise/Conversion
Incentive Stock Option (right to buy)
[F1][F4]
2021-08-03−4,170→ 0 total
Exercise: $23.98Exp: 2022-03-07→ Common Stock (4,170 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F4]
2021-08-03−27,830→ 0 total
Exercise: $23.98Exp: 2022-03-07→ Common Stock (27,830 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F4]
2021-08-03−16,225→ 0 total
Exercise: $26.49Exp: 2021-09-17→ Common Stock (16,225 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F4]
2021-08-03−1,775→ 158,225 total
Exercise: $27.07Exp: 2022-09-12→ Common Stock (1,775 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F4]
2021-08-04−38,225→ 120,000 total
Exercise: $27.07Exp: 2022-09-12→ Common Stock (38,225 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1][F4]
2021-08-04−11,775→ 108,225 total
Exercise: $27.07Exp: 2022-09-12→ Common Stock (11,775 underlying)

Footnotes (4)

[F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.09 to $35.51, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.57 to $35.58, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The shares subject to this option are fully vested and exercisable.

Signature

By: Nathan A. Smith For: Jerry S. Lanchbury|2021-08-05

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT